Related Experiment Video
Updated: Jun 15, 2025
10:47
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
Published on: February 3, 2015
8.7K
Recent advances in mitochondria-targeting theranostic agents
Kun Qian1, Shu Gao1,2, Zhaoning Jiang1,2,3
1State Key Laboratory of Drug Research Molecular Imaging Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China.
Exploration (Beijing, China)
|August 23, 2024
Summary
Mitochondria-targeting theranostic agents offer integrated diagnosis and therapy for diseases. These advanced materials precisely locate mitochondria, enabling simultaneous disease detection and treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cell Biology
Background:
- Mitochondria are crucial for cellular function and survival, implicating them in various diseases.
- Targeting mitochondria is a key strategy for developing novel diagnostic and therapeutic approaches.
- Theranostics integrate diagnostic and therapeutic capabilities into a single platform for simplified treatment and evaluation.
Purpose of the Study:
- To summarize recent advancements in mitochondria-targeting theranostic materials.
- To provide an overview of the background in mitochondria-targeting strategies and therapies.
- To offer updated insights and design concepts for the field of mitochondria-based theranostics.
Main Methods:
- Review of recent scientific literature on mitochondria-targeting theranostic agents.
- Analysis of design principles based on mitochondrial structure and composition.
- Synthesis of information on the application of these agents in disease contexts.
Main Results:
- Development of diverse theranostic agents with precise mitochondrial localization capabilities.
- Demonstration of simultaneous pathological information unveiling and therapeutic intervention.
- Highlighting the benefits of simplified treatment processes and efficient drug evaluation.
Conclusions:
- Mitochondria-targeting theranostics represent a promising integrated approach for disease management.
- Precise localization and dual functionality are key features of effective theranostic agents.
- Continued research in this area is expected to yield innovative design strategies and therapeutic outcomes.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
12.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.4K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:19Translocation of Proteins into the Mitochondria
3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K